Research Director. MSc and Ph.D. in Biology with a strong background in myotonic dystrophy (DM1) and in the biology of Muscleblind (Mbnl) proteins. She is part of the Arthex team, as Scientific Director contributing her excellent background in multiple biological disciplines, including biology, biochemistry, and genetics. She coordinates the development of new antimiR molecules, directed at new therapeutic targets. She is continuing improvement her knowledge in DM1 and she has demonstrated a record of productive research evidenced by my publications in many journals, including two papers in Nature Communications. She is also a co-inventor of the ARTHEx's foundational technology.